2 insiders bought €2,890 of shares over the last 90 days, the latest by Dipak Narendraprasad Patel, filed 11 Sept 2026.
Crestchem: what insiders have been doing
Crestchem, classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). From 9 November 2025 to 9 November 2026, the disclosure feed for Crestchem logged 20 filings by 6 insiders.
The record shows 13 purchases on the open market worth €6,217, made by 3 insiders, against 7 sales worth €18k by 3 insiders. The net balance comes to €12k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 3 senior executives. One trade stands out by size: a sale of €7,027 from Sonalben Dushyantbhai Patel, disclosed on 16 June 2026, or 0.20% of market capitalisation.
In the case of 7 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 60 days ago, on 11 September 2026. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 1,913 companies) published 4 filings over the same period, against 20 filings here. The full history, which starts in 2026, counts 13 purchases against 7 sales.
For comparison within the same sector, see the insider buying recorded at Symrise AG. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -25.4%Entry ₹154.45 · Close 06 Nov 2026 ₹115.15
- -25.4%Entry ₹154.45 · Close 06 Nov 2026 ₹115.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,042 shares@ ₹147.800.059% mcap100.0% of flowEquityMarket SaleSEBI:0a90c8d453e1f7932c830d575fc66c01db96c7c4
- 700 shares@ ₹133.100.018% mcap100.0% of flowEquityMarket SaleSEBI:f603965b1c44eef7509cf05d3cad03057b99d1d6
- 981 shares@ ₹131.900.025% mcap54.8% of flowEquityMarket PurchaseSEBI:e8f6d04fa5775432fa902eeb34365a01306a04ccCanonical exit: 10 Dec 2026 (T+90)
- 1,000 shares@ ₹130.000.025% mcap8.1% of flowEquityMarket SaleSEBI:cdfd68ce75063eede8f48225c31b1ff8924f150d
- 200 shares@ ₹132.400.0052% mcap100.0% of flowEquityMarket PurchaseSEBI:64fd6527a6b3d9f2d1db2b3e75a1cc3526aa20ceCanonical exit: 10 Dec 2026 (T+90)
- 200 shares@ ₹0.100.0000% mcap0.0% of flowEquityMarket PurchaseSEBI:5b57cedbfaea25754a2ba060ce979164fdc1dc6cCanonical exit: 9 Dec 2026 (T+90)
- 86 shares@ ₹126.800.0024% mcap2.5% of flowEquityMarket PurchaseSEBI:7e0aa3dc5d88a7a3ed0b8bf8728f8539dc496b28Canonical exit: 27 Nov 2026 (T+90)
- 437 shares@ ₹124.500.012% mcap12.7% of flowEquityMarket PurchaseSEBI:a83181c52bd13140f4f395a1e571520dfd0f824bCanonical exit: 25 Nov 2026 (T+90)
- 120 shares@ ₹107.800.0029% mcap3.0% of flowEquityMarket PurchaseSEBI:37bfbb173f11b73f7e7cdd0dcad315b3c1811ed6Canonical exit: 24 Nov 2026 (T+90)
- 200 shares@ ₹125.100.0055% mcap5.8% of flowEquityMarket PurchaseSEBI:3f6c245d88de0e06f472622dd96d66661bc33d02Canonical exit: 20 Nov 2026 (T+90)
- 500 shares@ ₹125.600.013% mcap14.6% of flowEquityMarket PurchaseSEBI:cfb2f72edece56388d57296c802a003e6e19d499Canonical exit: 18 Nov 2026 (T+90)
- 1,088 shares@ ₹129.300.030% mcap9.0% of flowEquity SharesMarket SaleSEBI:b3117a978129867b066dbd389a29698afe7b8456
- 2,500 shares@ ₹139.800.094% mcap22.6% of flowEquity SharesMarket SaleSEBI:d120559267cdc2423f4b896bcd5cfd84ca8a46c1
- 1,250 shares@ ₹140.700.047% mcap11.3% of flowEquity SharesMarket SaleSEBI:69ddb6e9ad1f8db3f7da7d46fc092a54f32426e5
- 1,000 shares@ ₹141.600.038% mcap34.1% of flowEquity SharesMarket PurchaseSEBI:053d85fb01070023d351813f9707f4e15c703e44Canonical exit: 21 Sept 2026 (T+90)
- 86 shares@ ₹142.600.0033% mcap2.9% of flowEquity SharesMarket PurchaseSEBI:6ec6715ddc9f6bc32ce9e2d19d58b9a3274f263eCanonical exit: 18 Sept 2026 (T+90)
- 500 shares@ ₹141.000.019% mcap16.9% of flowEquity SharesMarket PurchaseSEBI:aebca79103bb8675792ed8496c257edcbdb05ce9Canonical exit: 18 Sept 2026 (T+90)
- 220 shares@ ₹143.000.0083% mcap7.5% of flowEquity SharesMarket PurchaseSEBI:ac5fb3f0fdbf758b22dca44bf7e8f9846b8c2ff0Canonical exit: 15 Sept 2026 (T+90)
- 5,555 shares@ ₹138.900.20% mcap48.9% of flowEquity SharesMarket SaleSEBI:587983bd0eb9c25af40a4b79d1b536a3c6270534
- 790 shares@ ₹135.2045.2% of flowEquity SharesMarket PurchaseSEBI:a11959d636aeac2854a9b83b4597d218dfc14fcaCanonical exit: 1 Sept 2026 (T+90)
20 of 20 declarations
About Crestchem
Crestchem is a company listed on the XBOM, specializing in the chemical sector. It focuses on the production and distribution of various chemical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
